These results suggest that AP-1 was activated by LCA through the Src/EGFR-mediated ROS-dependent ERK1/2 signaling pathway, and that NF-κB was activated by LCA through the Src/EGFR-mediated ROS-dependent AKT signaling pathway. Here, MAPK3 is linked to Leber congenital amaurosis.